|本期目录/Table of Contents|

[1]王导.甲巯咪唑治疗甲状腺功能亢进症的效果及对肝功能的影响[J].慢性病学杂志,2018,(05):551-553.
 WANG Dao.Effect of methimazole on hyperthyroidism and its influence on liver function[J].,2018,(05):551-553.
点击复制

甲巯咪唑治疗甲状腺功能亢进症的效果及对肝功能的影响(PDF)

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
期数:
2018年05期
页码:
551-553
栏目:
论著
出版日期:
2018-05-20

文章信息/Info

Title:
Effect of methimazole on hyperthyroidism and its influence on liver function
作者:
王导
东莞市塘厦医院内二区,广东东莞523721
Author(s):
WANG Dao
The Second District of Medicine Department, Tangxia Hospital, Dongguan, Guangdong 523721, China Corresponding author: WANG Dao, E-mail: 840229449@qq.com
关键词:
:甲状腺功能亢进症丙硫氧嘧啶甲巯咪唑肝功能
Keywords:
Hyperthyroidism Propylthiouracil Methimazole Liver function
分类号:
R581.1
DOI:
-
摘要:
目的以治疗甲状腺功能亢进症的需求为重点,探讨采用巯咪唑(MMI) 治疗的临床效果及其对肝功能 的影响。方法选取东莞市塘厦医院2014 年8 月—2017 年3 月收治的94 例甲状腺功能亢进症患者,随机分为观 察组和对照组,每组47 例,两组分别给予甲巯咪唑和丙硫氧嘧啶口服治疗,连续用药12 个月,评价治疗前后两 组患者游离三碘甲腺原氨酸(FT3)、游离四碘甲腺原氨酸(FT4)、总三碘甲腺原氨酸(TT3) 及总四碘甲腺原 氨酸(TT4) 水平,并通过随访总胆红素(TBiL)、丙氨酸氨基转移酶(ALT)、天冬氨酸转氨酶(AST)、碱性 磷酸酶(ALP) 水平观察肝功能的变化情况。结果治疗前两组FT3、FT4、TT3 及TT4 比较无统计学差异 (P>0.05);治疗后,两组FT3、FT4、TT3 及TT4 均较治疗前明显降低(P<0.05),且观察组均低于对照组, 差异有统计学意义(P<0.05)。治疗前,两组患者TBiL、ALT、AST、ALP 等肝功能指标比较差异无统计学意 义(P>0.05);治疗后,两组TBiL、ALT、AST、ALP 水平均较治疗前升高,但观察组肝功能指标低于对照 组,差异有统计学意义(P<0.05)。两组不良反应发生率比较差异无统计学意义(P>0.05)。结论甲巯咪唑 治疗甲状腺功能亢进症效果显著,可降低甲状腺激素水平,对肝功能影响较小。
Abstract:
Objective To evaluate the clinical effect of methimazole on patients with hyperthyroidism and liver function for the treatment of hyperthyroidism. Methods A total of 94 patients with hyperthyroidism treated in Tangxia Hospital during August 2014 to March 2017 were randomly divided into observation group and control group (n=47) . The observation group and control group were given methimazole and propylthiouracil oral treatment for 12 months, respectively. The indexes such as free thyroxine 3 (FT3) , free thyroxine 4 (FT4) , total thyroxine 3 (TT3) and total thyroxine 4 (TT4) levels were compared before and after the treatment. Liver function represented by total bilirubin (TBiL) , glutamic-oxaloacetic transaminase (ALT) , alanine aminotransferase (AST) , alkaline phosphatase (ALP) levels was observed. Results The indexes such as FT3, FT4, TT3 and TT4 levels were not significantly different between the two groups before treatment (all P>0.05) , but which were significantly lower after treatment (P<0.05),especially in the observation group (all P<0.05) . There was no statistically significant difference in TBiL, ALT, AST, ALP levels in the two groups (all P<0.05) . After treatment, the levels of TBiL, ALT, AST and ALP in both groups were higher than those before treatment, and the aboved liver function indexes in the observation group werelower than those in the control group, and the differences were statistically significant (all P<0.05) . Conclusion Methimazole is effective in the treatment of hyperthyroidism, which can reduce thyroid hormone level and have less effect on liver function.

参考文献/References:

[1] 廖戮缪,蒙碧辉,陆丽莹.甲巯咪唑与丙硫氧嘧啶对甲状腺功能亢 进症肝功能影响的比较[J].广东医学,2014,35(8):1249.
[2] 董全文,战淑彩.药物治疗甲状腺功能亢进症的应用及分析[J].中 国实用医药,2010,5(35):34-35.
[3] 中华医学会内分泌学分会《中国甲状腺疾病诊治指》编写组.中 国甲状腺疾病诊治指南-甲状腺功能亢进症[J]. 中华内科杂志, 2007,46(10):876-882.
[4] 杜洪泉,刘玉,贾爱华,等.丙基硫氧嘧啶与甲巯咪唑对Graves 病 患者细胞因子的影响[J].中华内分泌代谢杂志,2012,28(9):737- 740.
[5] 朱红斌.甲巯咪唑与丙硫氧嘧啶治疗Graves甲状腺机能亢进症的 临床效果观察[J].医学理论与实践,2015,28(20):2796-2797.
[6] 林丽萍.甲巯咪唑与丙硫氧嘧啶治疗甲状腺机能亢进症Graves病 临床对比研究[J].中国医学工程,2014,22(9):25.
[7] 廖戮缪,蒙碧辉,陆丽莹.甲巯咪唑与丙硫氧嘧啶对甲状腺功能亢 进症肝功能影响的比较[J].广东医学,2014,35(8):1251.
[8] 李娜,张习敏,支婷婷,等.小剂量131I分别联合甲巯咪唑与丙硫氧 嘧啶治疗甲状腺功能亢进的效果比较[J]. 临床合理用药杂志, 2016,9(1):67-69.

备注/Memo

备注/Memo:
作者简介:王导,硕士研究生,主治医师,研究方向:内分泌科 通信作者:王导,E-mail: 840229449@qq.com
更新日期/Last Update: 2018-05-28